The next examination of the European Board of Neurology (EBN) will take place on Friday, 22 May 2020 at the EAN Congress in Paris.
Get a glimpse of the key highlights, insights, and standout moments from EAN 2025 in Helsinki, all captured in our Congress Review eBook.
Latest Posts
-
-
Health ministers and high-level representatives of the 53 Member States of the WHO European Region, as well as partner and civil society organizations, will take part in the 69th session of the WHO Regional Committee for Europe. The session took place at UN City, Copenhagen, Denmark, on 16–19 September 2019
-
Country of the MonthEur J Neurol
EUROPEAN JOURNAL OF NEUROLOGY: CONTRIBUTIONS FROM SWEDISH AUTHORS
October 1, 2019Please find below recent articles from Swedish authors that have been published in the European Journal of Neurology. -
Following the publication of its report on “The development of intercultural care and support for people with dementia from minority ethnic groups” in 2018, Alzheimer Europe has now launched an online repository of intercultural care initiatives, aimed at improving the situation of people with dementia and carers from minority ethnic backgrounds.
-
The 13th Baltic Sea Summer School on Epilepsy (BSSSE 13) took place for the second time in Rostock, Germany, from August 18 to 24, 2019. Participants were pleased to improve their knowledge in several areas of epilepsy in this beautiful Baltic Sea city, that harbors one of the oldest universities in Germany, for a full week.
-
Here are the first thress reports from those who took part in the EAN clincial Fellowships in 2019. Keep visitng EANpages over the next months to read more reports from other particpants from 2019.
-
Executive PageEAN NewsTop ArticlesFeatured Slider
Executive Page: update from President-Elect
October 1, 2019I am happy to share with you that Prof. Franz Fazekas’s health has greatly improved. We are in regular contact with him and his wife and expect (and wish) further recovery. Unfortunately, his current condition does not allow him to resume his function as President of our Society. As a consequence, the board has decided to ask me to take over his duties from September 1, 2019. To support the board and in accord with our bylaws, Prof. D. Vodusek, who already served in the EAN board, was appointed as member at large (until the next elections in Paris). I am very thankful to the entire board, the office, and particularly to Prof. G. Deuschl for their trust, support and advice in this delicate transition period. -
Paper of the MonthEAN NewsFeatured Slider
Paper of the month: Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report
October 1, 2019This month’s selected paper is a working group report that addresses a recently described disorder, limbic-predominant age-related TDP-43 encephalopathy (LATE), which is emerging as an important cause of cognitive impairment in the elderly. The group make recommendations for standardised neuropathological evaluation and identify research avenues to better understand this evolving new disease phenotype. -
Sweden, population 10 million, is the largest of the Nordic countries. The population is concentrated to the southern large-city areas, including the capital Stockholm (population 2 million) and the cities of Gothenburg and Malmö. Geographically, Sweden is the third largest country in the EU. The northern parts of the country extend above the artic circle, but the climate is relatively mild (average temperature about 0°C in January and 21°C in July) on account of the Gulf Stream carrying warmer Caribbean water to the region.!
-
Second dose of intravenous immunoglobulin for Guillain-Barre syndrome
-
Antiparanodal antibodies in CIDP.
-
Role of right frontal regions in cognition: evidence from intraoperative stimulation in awake people
-
Fluoroquinolone Use Linked to Higher Risk of Peripheral Neuropathy
-
EXTEND study: More evidence on thrombolysis beyond traditional time windows
-
A consensus review on the development of palliative care for patients with chronic and progressive neurological disease.